Can Omega-3 Fatty Acids Serve as a Preventive Strategy for Age-Related Macular Degeneration? A Systematic Review and Meta-Analysis
Chen KY, Chan HC, Chan CM
The Journal of nutrition · 0 citations
Review labels
Neutral facts our review recorded about how this study was done. They describe method, never whether we like the result.
How it was studied
- Design
- Meta-analysis (indexed by PubMed)
- Studied in
- People
- Main outcome
- Clinical events such as disease or death
Who paid for it
- Funding
- Funding not disclosed
Publication
- Published
- 2025-12-31 · J Nutr · vol. 156 · issue 2 · p. 101289
- Publisher
- Elsevier BV
- Cited
- 9 citations · more than 93% of similar papers · 3.1× the field average
- Impact
- Top 10% most cited in its field
- References
- 63 works
- Access
- Open access (repository copy)
- Research areas
- Retinal Diseases and Treatments · Fatty Acid Research and Health · Antioxidant Activity and Oxidative Stress
- Keywords
- Randomized controlled trial, Polyunsaturated fatty acid, Odds ratio, Odds, Prospective cohort study, Clinical trial, Restricted diet, MEDLINE
- MeSH
- humans, macular degeneration, fatty acids, omega-3, docosahexaenoic acids, eicosapentaenoic acid, dietary supplements, aged
3 authors
From TW
- Kai-Yang ChenChang Gung Memorial Hospital; Linkou Chang Gung Memorial Hospital
- Hoi-Chun Chan · correspondingChina Medical University
- Chi-Ming ChanFu Jen Catholic University; Cardinal Tien Hospital
Abstract
Background
Age-related macular degeneration (AMD) is a leading cause of irreversible vision loss in older adults. While anti-vascular endothelial growth factor (anti-VEGF) therapies are available for neovascular AMD (nAMD), effective preventive strategies remain limited. Long-chain omega-3 polyunsaturated fatty acids (ω-3 PUFAs), particularly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), have biological plausibility for retinal protection through structural roles in photoreceptor membranes and anti-inflammatory lipid mediator pathways.
Objectives
This study aimed to synthesize contemporary evidence regarding omega-3 fatty acids in AMD prevention, with emphasis on subtype-specific associations, differences by omega-3 species, and contrasts between dietary intake and supplementation evidence.
Methods
This systematic review and meta-analysis was conducted in accordance with PRISMA 2020 guidance and registered the protocol in PROSPERO (CRD420251122413). PubMed, ScienceDirect, and the Cochrane Library were searched from inception to August 2, 2025. Eligible studies included observational studies of dietary ω-3 PUFA exposure in adults aged 50 years or older with AMD outcomes. Random-effects models models were used to pool adjusted effect estimates comparing the highest versus lowest ω-3 exposure categories. Prespecified subgroup analyses were performed by AMD subtype (early AMD, advanced AMD, nAMD, and geographic atrophy [GA]) and ω-3 species (EPA, DHA, and alpha-linolenic acid [ALA]). Methodological quality was assessed using the Newcastle-Ottawa Scale (NOS). Publication bias was evaluated using funnel plots and Egger's regression test.
Results
Eighteen studies were included. Higher ω-3 intake was associated with reduced odds of AMD overall (odds ratio [OR] 0.82, 95% confidence interval [CI] 0.70-0.96; p = 0.01), with moderate heterogeneity (I² = 61%). Subtype analyses demonstrated stronger associations for nAMD (OR 0.57, 95% CI 0.40-0.81) and GA (OR 0.65, 95% CI 0.45-0.94), and a smaller association for early AMD (OR 0.83, 95% CI 0.72-0.97), whereas advanced AMD was not significantly different between high and low intake groups (OR 0.81, 95% CI 0.49-1.33; p = 0.41). In ω-3 species analyses, higher EPA intake was associated with lower AMD odds (OR 0.61, 95% CI 0.38-0.97; p = 0.04), while DHA showed a borderline association (OR 0.73, 95% CI 0.53-1.01; p = 0.05); ALA was not associated with benefit (OR 1.00, 95% CI 0.84-1.20; p = 0.96). Time-to-event pooling showed no significant long-term risk reduction (hazard ratio [HR] 0.98, 95% CI 0.84-1.15; p = 0.83). Funnel plot asymmetry was observed, and Egger's test suggested small-study effects (p = 0.04).
Conclusions
Higher dietary intake of marine-derived ω-3 PUFAs is associated with reduced odds of AMD. However, long-term risk reduction was not demonstrated in time-to-event analyses, and small-study effects were suggested. These findings support the possibility that dietary patterns emphasizing ω-3-rich seafood may contribute to AMD risk reduction, whereas the effectiveness of isolated ω-3 PUFA supplementation for AMD prevention remains uncertain and warrants confirmation in future prospective studies and larger randomized controlled trials with long-term follow-up.
Abstract via Europe PMC. Copyright remains with the authors or publisher.
Community trust
Loading…
How much do you trust this study's findings?
Comments
Sign in to rate, comment on or flag this study.Sign inSomething wrong here?
Flag this study if its information, labels or funding look wrong. An editor reviews every flag.
Sign in to rate, comment on or flag this study.Sign inEducational information about published research. Not medical advice, and not a recommendation to start or stop anything.